ALK and neoplasm: We performed next-generation sequencing on a cohort of 46 pediatric ALK+ ALCLs, including 42 tumor samples obtained at diagnosis and four relapsed samples (1 patient with paired diagnostic-relapsed samples) (Supplementary Figure S1).